Plunkett Research Online: Kindred Biosciences Inc

KINDRED BIOSCIENCES INC (KIN:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Kindred Biosciences Inc is a US-based development-stage biopharmaceutical company which focuses on developing medicines for pets. Its lead products candidates are the intravenous (IV) form of Zimeta which is a dipyrone injection for the control of pyrexia in horses and Mirataz which is a mirtazapine.....



Kindred Biosciences Inc
Ticker: KIN
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 650 701-7901
Fax:
Address: 1555 Bayshore Highway
Suite 200
Burlingame, CA 94010 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Veterinary Services
ContactsDescription
Richard ChinCEO/Co-Founder/Director/President
Wendy WeeCFO/Chief Accounting Officer
See More
Kindred Biosciences Inc is a US-based development-stage biopharmaceutical company which focuses on developing medicines for pets. Its lead products candidates are the intravenous (IV) form of Zimeta which is a dipyrone injection for the control of pyrexia in horses and Mirataz which is a mirtazapine.....See More See More

Auditor: KMJ Corbin & Company LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201320172016201520142013
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: